OTCPicks.com Stocks to Watch for Wednesday, August 20th GZGT, TCLT, RBDC, INRB, CHTL, VION

Our Stocks to Watch tomorrow include Guangzhou Global Telecom Inc. (OTCBB: GZGT), Techalt Inc. (OTC: TCLT), RBID.com Inc. (OTC: RBDC), Industrial Rubber Products Inc. (OTC: INRB), ChinaTel Group Inc. (OTCBB: CHTL) and Vion Pharmaceuticals Inc. (OTC: VION).

GUANGZHOU GLOBAL TELECOM INCORPORATED (OTCBB: GZGT)

"Up 133.33% on Tuesday"

Guangzhou Global Telecom, Inc. is a national mobile phone handset and pre- paid calling card distributor and provider of mobile handset value-added services. Maintaining cooperative relationships with China Telecom, China Mobile and China Unicom, the Company seeks to become the largest sales and distribution center of mobile phones, mobile phone parts and prepaid mobile phone cards in China. GTL plans to introduce new software and services through an expanded network of regional and neighborhood service centers, shops and virtual stores. For details, please visit our website at www.guangzhouglobaltelecom.com.

TECHALT INCORPORATED (OTC: TCLT)

"Up 100.00% on Tuesday"

Techalt is a public holding company dedicated to pursuing acquisition, licensing and financing opportunities with start-up and mid-stage companies. Techalt focuses on companies with innovative or alternative technologies, particularly in the software, communications, environmental and health and wellness sectors.

RBID.COM INCORPORATED (OTC: RBDC)

"Up 50.00% on Tuesday"

RBID.com, Inc. (www.rbid.com) is a financial IT and marketing company. RBID also facilitates the acquisition, commercialization, promotion and protection of both emerging patented and/or proprietary technologies. RBID.com, Inc has the exclusive US and European licensing and distribution rights to the home budgeting software, Simply Budgets (www.simplybudgets.com).

INDUSTRIAL RUBBER PRODUCTS INCORPORATED (OTC: INRB)

"Up 45.71% on Tuesday"

Founded in 1957, Industrial Rubber Products is a leading designer, producer, and applicator of elastomeric protective coatings for pipelines and other equipment used in demanding industrial applications. It serves U.S. and international customers in the energy, mining, aggregates, and other end markets. The company attracts and maintains strong customer relationships by utilizing proprietary compounds and manufacturing processes to create unique product solutions with performance and economic attributes superior to substitute products. Since the launch in late 2006 of the company's patent- pending IRACORE(TM) Pipe System, IRACORE has become the technology-leading pipe system for the fast growing oil sands industry in Canada and is beginning to penetrate other end markets.

CHINATEL GROUP INCORPORATED (OTCBB: CHTL)

"Up 60.87% on Tuesday"

ChinaTel owns Trussnet USA, Inc., a Nevada corporation, a recently formed company that will provide telecommunications infrastructure engineering and construction services in mainland China. Trussnet and its direct and indirect subsidiaries have entered into a series of agreements to build and deploy a 3.5GHz wireless broadband system in up to 29 cities across the People’s Republic of China (PRC) with and for CECT-Chinacomm Communications Co., Ltd., a PRC company that holds a license to build such WiMAX systems. For more information, visit www.chinatelgroup.com.

VION PHARMACEUTICALS INCORPORATED (OTC: VION)

"Up 40.63% on Tuesday"

Vion Pharmaceuticals, Inc. is committed to extending the lives and improving the quality of life of cancer patients worldwide by developing and commercializing innovative cancer therapeutics. Vion has two agents in clinical trials. Laromustine (Cloretazine® (VNP40101M)), a unique alkylating agent, is being evaluated in a Phase II pivotal trial as a single agent in elderly patients with previously untreated de novo poor-risk acute myelogenous leukemia. Clinical trials of Cloretazine® (VNP40101M) with cytarabine in elderly patients with acute myelogenous leukemia, with temozolomide in brain tumors, and with stem cell transplantation in advanced hematologic malignancies, are also being conducted. Triapine®, a potent inhibitor of a key step in DNA synthesis, is being evaluated in clinical trials sponsored by the National Cancer Institute.

About OTCPicks.com

Forward-Looking Statement: This press release includes "forward-looking statements" within the meaning of the federal securities laws, commonly identified by such terms as "believes," "looking ahead," "anticipates," "estimates" and other terms with similar meaning. Although the Company believes that the assumptions upon which its forward-looking statements are based are reasonable, it can give no assurance that these assumptions will prove to be correct. Important factors that could cause actual results to differ materially from the Company's projections and expectations are disclosed in the Company's filings with the Securities and Exchange Commission. All forward-looking statements in this press release are expressly qualified by such cautionary statements and by reference to the underlying assumptions.

Disclosure: OTCPicks.com has not been compensated by any of the companies covered in this release.

OTCPicks.com is not a registered investment advisers or broker/dealer. OTCPicks.com makes no recommendation that the purchase of securities of companies profiled in this website is suitable or advisable for any person or that an investment such securities will be profitable. In general, given the nature of the companies profiled and the lack of an active trading market their securities, investing in such securities is highly speculative and carries a high degree of risk.